Pfizer-BioNTech ask FDA for emergency use authorization for COVID vaccine for children 5 to 11
If authorized, this would be the first Covid-19 vaccine for younger children.
The Facts Inside Our Reporter’s Notebook
Pharmaceutical companies Pfizer and BioNTech on Thursday asked the Food and Drug Administration for emergency use authorization from for their joint COVID-19 vaccine for children 5 to 11 years old.
If the federal agency grant the authorized, the companies' vaccine would be the first such for that age group. Their vaccine is approved for those 16 and older, and they have EUA approval for people ages 12 to 15, according to CNN.
Just News, No Noise
- Boomerang? DOJ admission it over-collected evidence in Trump raid creates new legal drama
- Impeachment Republicans' last stand? Cheney, Murkowski face Trump-backed primary challengers
- Lawyers for targeted journalist slam AG Garland's 'outrageous and illegal abuses' of Biden critics
- Fox's Laura Ingraham: 'Exhausted' voters may be ready 'to turn the page' on Trump
- Scientists shred new research for mask mandates as 'junk science,' 'irredeemably flawed'